Addressing emotional and physical distress after pulmonary embolism
Researchers have spent many years developing improved medical treatments for pulmonary embolism (PE), such as development of the direct oral anticoagulants, outpatient management of PE and optimization of treatments for cancer-associated PE. Much of this research has focused on reducing venous thrombotic recurrence and reducing bleeding complications, with success measured in terms of absolute risk reduction. Evidence-based medicine assumes that reduction in a measurable untoward outcome translates into improved patient-centered care.
Source: Thrombosis Research - Category: Hematology Authors: Kerstin de Wit Tags: Editorial Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Hematology | Oral Cancer | Pulmonary Thromboembolism | Thrombosis